Feedback between glial tumor necrosis factor-α and gp120 from HIV-infected cells helps maintain infection and destroy neurons

NeuroImmunoModulation

Volumn 10, Issue 2, 2002, Pages 85-92

  Kast, Richard E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

CD 4; Glia; Gp120; HIV; Inflammation; Lymphocyte; Monocyte; Neuron; Tumor necrosis factor

Indexed keywords

GLYCOPROTEIN GP 120; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINEAGE; CYTOKINE PRODUCTION; GLIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MICROENVIRONMENT; MONOCYTE; NEGATIVE FEEDBACK; NERVE CELL LESION; NONHUMAN; PATHOPHYSIOLOGY; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR OCCUPANCY; UPREGULATION; VIRUS REPLICATION;

FEEDBACK, BIOCHEMICAL; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; NEUROGLIA; NEUROIMMUNOMODULATION; NEURONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036424311     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065184     Document Type: Article

References (86)

1. Viviani B, Corsini E, Binaglia M, Galli CL, Marinovich M: Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus gp120 in vitro. Neuroscience 2001;107:51-58.
2. Goplen AK, Liestol K, Dunlop O, Bruun JN, Maehlen J: Dementia in AIDS patients in Oslo. Scand J Infect Dis 2001;33:755-758.
3. Corasanti MT, Maccarrone M, Nistico R, Malorni W, Rotiroti D, Bagetta G: Exploitation of the coat glycoprotein gp120 in neurodegenerative studies in vivo. J Neurochem 2001;79:1-8.
4. Viel JJ, McManus DQ, Smith SS, Brewer GJ: Age and concentration dependent neuroprotection and toxicity by TNF in cortical neurons from beta amyloid. J Neurosci Res 2001;64:454-465.
5. Hemmer K, Fransen L, Vanderstichele H, Vanmechelen E, Heuschling P: An in vitro model for the study of microglia induced neurodegeneration: Involvement of nitric oxide and TNF. Neurochem Int 2001;38:557-565.
6. Nicholas RS, Compston A, Brown DR: Inhibition of TNF induced NFkB p52 converts the metabolic effects of microglial derived TNF on mouse cerebellar neurons to neurotoxicity. J Neurochem 2001;76:1431-1438.
7. Bezzi P, Domercq M, Brambilla L, et al: CXCR4 activated astrocyte glutamate release via TNF; amplification by microglia triggers neurotoxicity. Nat Neurosci 2001;4:676-678.
8. Sairanen T, Carpen O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen U, Kaste M, Lindsberg PJ: Evolution of cerebral TNF production during human ischemic stroke. Stroke 2001;32:1750-1758.
9. Daigle JL, Hong JH, Chiang CS, McBride WH: The role of TNF signaling pathways in the response of murine brain to irradiation. Cancer Res 2001;61:8859-8865.
10. Barker V, Middleton G, Davey F, Davies AM: TNF contributes to the death of NGF dependent neurons during development. Nat Neurosci 2001;4:1194-1198.
11. Robertson J, Beaulieu JM, Doroudchi MM, Durham HD, Julien JP, Mushynski WE: Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine TNF. J Cell Biol 2001;155:217-226.
12. Hermann GE, Rogers RC, Bresnahan JC, Beattie MS: TNF induces cFos and strongly potentiates glutamate mediated cell death in the rat spinal cord. Neurobiol Dis 2001;8:590-599.
13. Tezel G, Li LY, Patil RV, Wax MB: TNF and TNF R1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001;42:1787-1794.
14. Reimann-Philipp U, Ovase R, Weigel PH, Grammas P: Mechanisms of cell death in primary cortical neurons and PC12 cells. J Neurosci Res 2001;64:654-660.
15. Zhao X, Bausano B, Pike BR, et al: TNF stimulates caspase-3 activation and apoptotic cell death in primary septohippocampal cultures. J Neurosci Res 2001;64:121-131.
16. Oyaizu N, McCloskey TW, Than S, Hu R, Pahwa S: Mechanism of apoptosis in peripheral blood mononuclear cells of HIV-infected patients. Adv Exp Med Biol 1995;374:101-114.
17. Clouse KA, Cosentino LM, Weih KA, Pyle SW, Robbins PB, Hochstein HD, Natarajan V, Farrar WL: The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991;147:2892-2901.
18. Tamma SM, Chirmule N, Yagura H, Oyaizu N, Kalyanaraman V, Pahwa S: CD4 cross-linking (CD4XL) induces RAS activation and tumor necrosis factor-alpha secretion in CD4+ T cells. Blood 1997;90:1588-1593.
19. Than S, Oyaizu N, Tetali S, Romano J, Kaplan M, Pahwa S: Upregulation of human immunodeficiency virus (HIV) replication by CD4 cross-linking in peripheral blood mononuclear cells of HIV infected adults. J Virol 1997;71:6230-6232.
20. Chowdhury MI, Koyanagi Y, Horiuchi S, Hazeki O, Ui M, Kitano K, Golde DW, Takada K, Yamamoto N: cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrohage lineage: Synergism with TNF-alpha. Virology 1993;194:345-349.
21. Karin M: The beginning of the end: IkB kinase (IKK) and NFkB activation. J Biol Chem 1999;274:27339-27342.
22. Hatada EN, Krappmann D, Scheidereit C: NFkB and the innate immune response. Curr Opinion Immunol 2000;12:52-58.
23. Liu QN, Reddy S, Sayre JW, Pop V, Graves MC, Fiala M: Essential role of HIV infected and COX-2 activated macrophages and T cells in HIV myocarditis. AIDS Res Hum Retroviruses 2001;17:1423-1433.
24. Kast RE: NSAIDs might also be pro-inflammatory by increasing TNF. Biomed Pharmacother 2000;54:168-169.
25. Kast RE: TNF has positive and negative self-regulatory feedback cycles centered on cAMP. Int J Immunopharmacol 2000;22:1001-1006.
26. Maccarrone M, Bari M, Corasaniti MT, Nistico R, Bagetta G, Finazzi-Agro A: HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids. J Neurochem 2000;75/1:196-203.
27. Maccarrone M, Navarra M, Corasaniti MT, Nistico G, Finazzi Agro A: Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade. Biochem J 1998;333/1:45-49.
28. Bagetta G, Corasaniti MT, Paoletti AM, Berliocchi L, Nistico R, Giammarioli AM, Malorni W, Finazzi-Agro A: HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygenase type 2 (COX-2). Biochem Biophys Res Commun 1998;244:819-824.
29. Tarter TH, Cunningham-Rundles S, Laurence J, Koide SS: Soluble factor of transformed B lymphocytes in patients with HIV infection stimulates monocytes to produce PGE2. Clin Immunol Immunopathol 1997;82:303-306.
30. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE: Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995;182:941-951.
31. Yeh MW, Kaul M, Zheng J, Nottet HS, Thylin M, Gendelman HE, Lipton SA: Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of 1-cysteine. J Immunol 2000;164:4265-4270.
32. Yeung MC, Pulliam L, La AS: The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS 1995;9/2:137-143.
33. Westmoreland SV, Kolson D, Gonzalez-Scarano F: Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementia. J Neurovirol 1996;2/2:118-126.
34. Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS: Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 1992;66:2217-2225.
35. Kong LY, Wilsong BC, McMillian MK, Bing G, Hudson PM, Hong JS: The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996;172/1:77-83.
36. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS: Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 1998;85/1:1-10.
37. Antinori A, Giancola ML, Alba L, Soldani F, Grisetti S: Cardiomyopathy and encephalopathy in AIDS. An NY Acad Sci 2001;946:121-129.
38. Fischer-Smith T, Croul S, Sverstiuk AE, et al: CNS invasion by CD14+/CD16+ peripheral blood derived monocytes in HIV dementia; perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001;7:528-541.
39. Williams K, Alvarez X, Lackner AA: CNS perivascular cells are immunoregulatory cells that connect that CNS with the peripheral immune system. Glia 2001;36:156-164.
40. Glass JD, Wesselingh SL: Microglia in HIV associated neurological diseases. Microsc Res Tech 2001;54:95-105.
41. Gorry PR, Bristol G, Zach JA, et al: Macrophage tropism of HIV-1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 2001;75:10073-10089.
42. McClernon DR, Lanier R, Gartner S, et al: HIV in the brain; RNA levels and patterns of zidovudine resistance. Neurology 2001;57:1396-1401.
43. Kandanearatchi A, Zuckerman M, Smith M, Vyakarnam A, Everall IP: GM-CSF enhances viral load in human brain tissue: Amelioration with stavudine. AIDS 2002;16:413-420.
44. Kaminska T, Hus I, Dmoszynska A, Kandefer-Szerszen M: Cytokine production in whole blood cell cultures of patients with B cell lineage acute lymphoblastic leukemia. The influence of GM-CSF. Arch Immunol Ther Exp 2001;49:71-77.
45. Coronel A, Boyer A, Franssen JD, Romat-Lemonne JL, Fridman WH, Teillaud JL: Cytokine production and T cell activation by macrophage dendritic cells generated for therapeutic use. Br J Haematol 2001;114:671-680.
46. Kaminska T, Hus I, Dmoszynska A, Kandefer-Szerszen M: Effect of GM-CSF on interferon and TNF production in whole blood cell cultures of patients with acute myelogenous leukemia. Arch Immunol Ther Exp 2001;49(suppl 2):S83-87.
47. Martinez-Jaramillo G, Flores-Figuerosa E, Gomez-Morales E, Sanchez-Valle E, Mayani H: TNF levels in long term marrow cultures from patients with aplastic anemia: Modulation by GM-CSF. Am J Hematol 2001;68:144-148.
48. Combs CK, Karlo JC, Kao SC, Landreth GE: β-Amyloid stimulation of microglia and monocytes results in TNF dependent expression of iNOS and neuronal apoptosis. J Neurosci 2001;21:1179-1188.
49. Viviani B, Corsini E, Galli CL, Padovani A, Ciusani E, Marinovich M: Dying neural cells activate glia through release of a protease product. Glia 2000;32:84-90.
50. Kast RE: Statins in dementia. Lancet 2001;357:881.
51. Skovronsky DM, Fath S, Lee VM, Milla MA: Neuronal localization of TACE in brain tissue and its correlation to amyloid plaque. J Neurobiol 2001;49:40-46.
52. Kast RE, Altschuler EL: Remission of Crohn's disease on bupropion. Gastroenterology 2001;121:1260-1261.
53. Kast RE: Bupropion Lowers Circulating TNF in Humans. Submitted.
54. Rosenson RS, Tangney CC, Casey LC: Inhibition of proinflammatory cytokine production by pravastatin. Lancet 1999;353:983-984.
55. Musial J, Undas A, Gajewski P, Jankowski M, Sydor W, Szczeklik A: Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol 2001;77/2-3:247-253.
56. Weis M, Pehlivanli S, Meiser BM, van Scheidt W: Simvastatin treatment is associated with decreased cytokine activation in patients after heart transplant. J Am Coll Cardiol 2001;38:814-818.
57. Ferro D, Parrotto S, Basili S, Alessandri C, Violi F: Simvastatin inhibits the monocyte expression of pro-inflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 2000;36:427-431.
58. Levi G, Patrizio M, Bernardo A, Petrucci TC, Agresti C: Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc Natl Acad Sci USA 1993;90:1541-1545.
59. Patke CL, Shearer WT: gp120- and TNF-alpha-induced modulation of human B cell function: Proliferation, cyclic AMP generation, Ig production, and B-cell receptor expression. J Allergy Clin Immunol 2000;105:975-982.
60. Butera ST, Perez VL, Wu BY, Nabel GJ, Folks TM: Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J Virol 1991;65:4645-4653.
61. Reuben JM, Gonik B, Li S, Loo L, Turpin J: Induction of cytokines in normal placental cells by the human immunodeficiency virus. Lymphokine Cytokine Res 1991;10/3:195-199.
62. Tanaka J, Ozaki H, Yasuda J, Horai R, Tagawa Y, Asano M, Saijo S, Imai M, Sekikawa K, Kopf M, Iwakura Y: LPS induced HIV expression in transgenic mice is mediated by TNF and IL-1 but not by IFN-gamma nor IL-6. AIDS 2000;14:1299-1307.
63. Shatrov VA, Ratter F, Gruber A, Droge W, Lehmann V: HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells. AIDS Res Hum Retroviruses 1996;12:1209-1216.
64. Okamoto M, Ono M, Baba M: Suppression of cytokine production and neural death by the anti-inflammatory alkaloid cepharanthine. Biochem Pharmacol 2001;62:747-753.
65. Maciejewski JP, Weichold FF, Young NS: HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol 1994;153:4303-4310.
66. Tyring SK, Cauda R, Tumbarello M, Ortona L, Kennedy RC, Chanh TC, Kanda P: Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress productiong of interferon-alpha, interferon-gamma and interleukin-2. Viral Immunol 1991;4/1:33-42.
67. Capobianchi MR: Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis. J Biol Regul Homeost Agents 1996;10/4:83-91.
68. Ilyin SE, Plata-Salaman CR: HIV-1 gp120 modulates hypothalamic cytokine mRNAs in vivo: Implications to cytokine feedback systems. Biochem Biophys Res Commun 1997;231:514-518.
69. Herzberg U, Sagen J: Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol 2001;116/1:29-39.
70. Ilyin SE, Plata-Salaman CR: HIV-1 envelope glycoprotein 120 regulates brain IL-2 beta system and TNF-alpha mRNAs in vivo. Brain Res Bull 1997;44/1:67-73.
71. Floyd RA, Hensley K, Jaffery F, Maidt L, Robinson K, Pye Q, Stewart C: Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps. Life Sci 1999;65:1893-1899.
72. Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Okumura K, Kaneko Y: Role of tumour necrosis factor-alpha (TNF-alpha) in the induction of HIV-1 gp120-mediated CD4+ T cell anergy. Clin Exp Immunol 1997;109/1:41-46.
73. Takeda-Hirokawa N, Neoh LP, Akimoto H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Hirose S, Murakami T, Yamamoto N, Mimura T, Kaneko Y: Role of curdlan sulfate in the binding of HIV-1 gp120 to CD4 molecules and the production of gp120-mediated TNF-alpha. Microbiol Immunol 1997;41:741-745.
74. Karsten V, Gordon S, Kirn A, Herbein G: HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha. Immunology 1996;88/1:55-60.
75. Yoshioka M, Bradley WG, Shapshak P, Nagano I, Stewart RV, Xin KQ, Srivastava AK, Nakamura S: Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv Neuroimmunol 1995;5: 335-358.
76. Zauli G, Gibellini D, Secchiero P, Dutarte H, Olive D, Capitani S, Collette Y: HIV-1 Nef protein sensitizes CD4+ T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95L pathway. Blood 1999;93:1000-1010.
77. Rasola A, Gramaglia D, Boccaccio C, Comoglio PM: Apoptosis enhancement by the HIV Nef protein. J Immunol 2001;166:81-88.
78. Trillo-Pazos G, McFarlane-Abdulla E, Campbell IC, Pilkington GJ, Everall IP: Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res 2000;864:315-326.
79. Xu XN, Laffert B, Screaton GR, et al: Induction of FasL expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 1999;189:1489-1496.
80. Ramirez SH, Sanchez JF, Dimitri CA, Gelbard HA, Dewhurst S, Maggirwar SB: Neurotrophins prevent HIV Tat induced neuronal apoptosis via a NFkB dependent mechanism. J Neurochem 2001;78:874-889.
81. Perez A, Probert AW, Wang KK, Sharmeen L: Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol 2001;7:1-10.
82. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD: HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 2001;78:457-467.
83. Zhu Y, Gelbard MA, Roshal M, Pursell S, Jamieson BD, Planelles V: Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type vpr genes. J Virol 2001;75:3791-3801.
84. Watanabe N, Yamagchi T, Akimoto Y, Rattner JB, Hirano H, Nakauchi H: Induction of M phase arrest and apoptosis after HIV vpr expression through uncoupling of nuclear centrosomal cycle in HeLa cells. Exp Cell Res 2000;258:261-269.
85. Deora A, Ratner L: Vpu mediated enhancement of HIV particle release depends on the rate of cellular proliferation. J Virol 2001;75:6714-6718.
86. Bour S, Perrin C, Akari H, Strebel K: Tne HIV-1 vpu protein inhibits NFkB activation by interfering with beta TrCP mediated degradation of IkB. J Biol Chem 2001;276:15920-15928.